| 20.1 |
60.2 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 11.5 |
46.0 |
GO:0098763 |
mitotic cell cycle phase(GO:0098763) |
| 10.9 |
32.6 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 10.4 |
31.3 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 10.4 |
124.5 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 9.9 |
39.6 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 9.6 |
28.7 |
GO:0016321 |
female meiosis chromosome segregation(GO:0016321) |
| 9.4 |
28.1 |
GO:0030862 |
neuroblast division in subventricular zone(GO:0021849) regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 8.8 |
26.5 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 8.7 |
26.0 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 8.2 |
24.6 |
GO:1900060 |
negative regulation of ceramide biosynthetic process(GO:1900060) |
| 8.1 |
24.4 |
GO:0035910 |
ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 8.0 |
24.0 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 7.9 |
31.4 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 7.8 |
31.2 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 7.6 |
22.9 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 7.6 |
15.1 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 7.6 |
22.7 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 7.5 |
44.9 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 7.3 |
29.1 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 7.2 |
122.0 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 7.2 |
43.0 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 7.1 |
42.8 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 7.1 |
28.4 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 6.8 |
74.8 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 6.6 |
26.5 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 6.5 |
19.4 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 6.4 |
12.9 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 6.2 |
18.7 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) cardiac cell fate determination(GO:0060913) |
| 6.2 |
6.2 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 6.2 |
18.5 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 6.1 |
42.9 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 6.0 |
17.9 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 6.0 |
6.0 |
GO:0031052 |
programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
| 5.8 |
17.4 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 5.8 |
23.1 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 5.5 |
16.5 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 5.5 |
21.9 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 5.2 |
15.7 |
GO:0072180 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 5.2 |
73.1 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 4.9 |
4.9 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 4.9 |
58.9 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 4.9 |
24.4 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 4.8 |
33.8 |
GO:0070092 |
regulation of glucagon secretion(GO:0070092) |
| 4.8 |
19.3 |
GO:0051595 |
response to methylglyoxal(GO:0051595) |
| 4.8 |
9.6 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 4.8 |
14.3 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 4.7 |
14.2 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 4.7 |
9.4 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 4.6 |
18.5 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 4.5 |
35.7 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 4.5 |
49.0 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 4.4 |
17.8 |
GO:0021937 |
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 4.4 |
17.7 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 4.4 |
13.2 |
GO:0060729 |
intrahepatic bile duct development(GO:0035622) intestinal epithelial structure maintenance(GO:0060729) renal vesicle induction(GO:0072034) |
| 4.3 |
17.2 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 4.2 |
12.7 |
GO:0090526 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 4.2 |
33.5 |
GO:0033504 |
floor plate development(GO:0033504) |
| 4.1 |
20.6 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 4.1 |
48.7 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 4.0 |
12.0 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 4.0 |
15.8 |
GO:0060266 |
negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 3.9 |
19.6 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 3.8 |
22.6 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 3.8 |
11.3 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 3.8 |
11.3 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 3.7 |
59.8 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 3.7 |
26.0 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 3.7 |
22.1 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 3.7 |
11.1 |
GO:0061197 |
fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) |
| 3.7 |
11.0 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 3.6 |
10.9 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 3.6 |
14.3 |
GO:0042637 |
catagen(GO:0042637) |
| 3.5 |
39.0 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 3.5 |
10.5 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 3.5 |
101.3 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 3.4 |
30.3 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 3.4 |
10.1 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 3.3 |
103.7 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 3.3 |
13.1 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 3.2 |
6.4 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 3.2 |
16.1 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 3.1 |
37.5 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 3.1 |
18.7 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 3.1 |
9.3 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 3.1 |
12.4 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 3.1 |
9.2 |
GO:0090202 |
transcriptional activation by promoter-enhancer looping(GO:0071733) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 3.1 |
12.3 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 3.1 |
9.2 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 3.0 |
12.1 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 3.0 |
18.0 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 3.0 |
3.0 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 3.0 |
8.9 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 3.0 |
3.0 |
GO:0044332 |
Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 3.0 |
8.9 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) calcium-independent cell-matrix adhesion(GO:0007161) |
| 2.8 |
11.3 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 2.8 |
8.4 |
GO:0031627 |
telomeric loop formation(GO:0031627) |
| 2.8 |
8.4 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 2.8 |
19.5 |
GO:0051304 |
chromosome separation(GO:0051304) |
| 2.8 |
5.5 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 2.8 |
63.5 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 2.7 |
8.2 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 2.7 |
8.0 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
| 2.6 |
13.0 |
GO:0060594 |
mammary gland specification(GO:0060594) |
| 2.6 |
10.3 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 2.5 |
2.5 |
GO:0002645 |
positive regulation of tolerance induction(GO:0002645) |
| 2.5 |
9.9 |
GO:0072282 |
metanephric nephron tubule morphogenesis(GO:0072282) |
| 2.5 |
7.4 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 2.4 |
53.9 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 2.4 |
24.4 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 2.4 |
17.0 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 2.4 |
36.3 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 2.4 |
9.6 |
GO:0060066 |
oviduct development(GO:0060066) |
| 2.4 |
7.1 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 2.4 |
9.5 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 2.4 |
4.7 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 2.3 |
7.0 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 2.3 |
49.1 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 2.3 |
9.2 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 2.3 |
4.6 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 2.3 |
15.9 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 2.3 |
11.3 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 2.3 |
9.0 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 2.2 |
6.7 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 2.2 |
15.7 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 2.2 |
11.1 |
GO:0006544 |
glycine metabolic process(GO:0006544) |
| 2.2 |
8.8 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 2.2 |
15.4 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 2.2 |
8.7 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 2.2 |
41.3 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 2.1 |
10.7 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 2.1 |
6.4 |
GO:2001053 |
regulation of mesenchymal cell apoptotic process(GO:2001053) |
| 2.1 |
12.8 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 2.1 |
10.6 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 2.1 |
21.1 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 2.1 |
20.9 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 2.1 |
4.2 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 2.1 |
10.4 |
GO:1901970 |
positive regulation of mitotic sister chromatid separation(GO:1901970) |
| 2.1 |
2.1 |
GO:0051299 |
centrosome separation(GO:0051299) |
| 2.0 |
16.3 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 2.0 |
22.4 |
GO:0030238 |
male sex determination(GO:0030238) |
| 2.0 |
14.1 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 2.0 |
6.0 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 2.0 |
13.8 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 2.0 |
3.9 |
GO:0072038 |
mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
| 1.9 |
9.7 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 1.9 |
23.1 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 1.9 |
3.8 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 1.9 |
5.6 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 1.9 |
5.6 |
GO:1905065 |
positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 1.9 |
5.6 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 1.9 |
5.6 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 1.8 |
3.7 |
GO:0021861 |
forebrain radial glial cell differentiation(GO:0021861) |
| 1.8 |
12.6 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 1.8 |
25.2 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 1.8 |
10.8 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 1.7 |
8.7 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 1.7 |
8.7 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 1.7 |
10.4 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 1.7 |
3.5 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 1.7 |
5.2 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 1.7 |
30.7 |
GO:0045589 |
regulation of regulatory T cell differentiation(GO:0045589) |
| 1.7 |
8.5 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 1.7 |
5.1 |
GO:0061314 |
Notch signaling involved in heart development(GO:0061314) |
| 1.7 |
5.1 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 1.7 |
6.8 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 1.7 |
15.3 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 1.7 |
15.2 |
GO:0070244 |
negative regulation of thymocyte apoptotic process(GO:0070244) |
| 1.7 |
5.1 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 1.7 |
10.1 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 1.7 |
13.5 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 1.7 |
16.8 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 1.7 |
6.7 |
GO:0002339 |
B cell selection(GO:0002339) |
| 1.7 |
10.0 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 1.7 |
3.3 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 1.7 |
6.6 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 1.6 |
6.6 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 1.6 |
9.8 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 1.6 |
4.9 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 1.6 |
6.5 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 1.6 |
9.7 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 1.6 |
21.0 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 1.6 |
4.8 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 1.6 |
6.4 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 1.6 |
23.9 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 1.6 |
34.8 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 1.6 |
7.9 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.6 |
71.9 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 1.6 |
1.6 |
GO:0071609 |
chemokine (C-C motif) ligand 5 production(GO:0071609) |
| 1.5 |
4.6 |
GO:0046671 |
negative regulation of retinal cell programmed cell death(GO:0046671) |
| 1.5 |
9.1 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 1.5 |
16.7 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 1.5 |
6.0 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 1.5 |
9.0 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 1.5 |
14.7 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 1.5 |
4.4 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 1.5 |
14.7 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 1.5 |
5.9 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 1.4 |
5.8 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 1.4 |
7.1 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 1.4 |
5.6 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 1.4 |
5.6 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 1.4 |
16.6 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 1.4 |
12.2 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 1.3 |
24.3 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 1.3 |
31.0 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 1.3 |
2.7 |
GO:0071865 |
regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
| 1.3 |
14.7 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 1.3 |
4.0 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 1.3 |
1.3 |
GO:1903748 |
negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 1.3 |
2.7 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 1.3 |
5.3 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 1.3 |
2.6 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 1.3 |
5.2 |
GO:0034238 |
macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
| 1.3 |
3.9 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 1.3 |
2.6 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 1.3 |
9.1 |
GO:0034766 |
negative regulation of ion transmembrane transport(GO:0034766) |
| 1.3 |
32.4 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 1.3 |
10.4 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 1.3 |
6.5 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 1.3 |
29.4 |
GO:0007099 |
centriole replication(GO:0007099) |
| 1.3 |
3.8 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 1.3 |
2.5 |
GO:0007530 |
sex determination(GO:0007530) |
| 1.3 |
7.5 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 1.2 |
10.0 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 1.2 |
6.2 |
GO:2000780 |
negative regulation of double-strand break repair(GO:2000780) |
| 1.2 |
8.6 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 1.2 |
3.6 |
GO:2000768 |
positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 1.2 |
10.9 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 1.2 |
21.5 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 1.2 |
9.5 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 1.2 |
4.7 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 1.2 |
5.9 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 1.2 |
1.2 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 1.2 |
4.6 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 1.2 |
12.7 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 1.2 |
2.3 |
GO:0052548 |
regulation of endopeptidase activity(GO:0052548) |
| 1.1 |
10.2 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
| 1.1 |
14.7 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 1.1 |
4.5 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) |
| 1.1 |
4.5 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 1.1 |
4.4 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 1.1 |
4.4 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 1.1 |
15.3 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 1.1 |
5.5 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 1.1 |
22.9 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 1.1 |
3.2 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 1.1 |
3.2 |
GO:0046666 |
retinal cell programmed cell death(GO:0046666) |
| 1.1 |
6.4 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 1.1 |
6.4 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 1.1 |
5.3 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 1.1 |
4.3 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 1.1 |
5.3 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 1.0 |
22.0 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 1.0 |
18.8 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 1.0 |
19.8 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 1.0 |
2.1 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 1.0 |
10.4 |
GO:0060065 |
uterus development(GO:0060065) |
| 1.0 |
4.2 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 1.0 |
17.6 |
GO:2000779 |
regulation of double-strand break repair(GO:2000779) |
| 1.0 |
14.5 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 1.0 |
5.2 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 1.0 |
8.3 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 1.0 |
6.1 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 1.0 |
10.2 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 1.0 |
2.0 |
GO:0001705 |
ectoderm formation(GO:0001705) |
| 1.0 |
3.0 |
GO:0043277 |
apoptotic cell clearance(GO:0043277) |
| 1.0 |
2.0 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 1.0 |
8.0 |
GO:0042754 |
negative regulation of circadian rhythm(GO:0042754) |
| 1.0 |
323.4 |
GO:0007067 |
mitotic nuclear division(GO:0007067) |
| 1.0 |
3.0 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 1.0 |
3.0 |
GO:1904936 |
globus pallidus development(GO:0021759) cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 1.0 |
3.0 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 1.0 |
8.9 |
GO:0048665 |
neuron fate specification(GO:0048665) |
| 1.0 |
4.9 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 1.0 |
3.9 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 1.0 |
9.7 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 1.0 |
7.7 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 1.0 |
8.6 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.9 |
1.9 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.9 |
0.9 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.9 |
22.3 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.9 |
2.8 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.9 |
5.5 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.9 |
1.8 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.9 |
23.0 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.9 |
8.3 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.9 |
3.7 |
GO:0031657 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
| 0.9 |
3.7 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.9 |
2.7 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.9 |
12.5 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.9 |
0.9 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.9 |
0.9 |
GO:0032875 |
regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
| 0.9 |
2.6 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.9 |
5.2 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.9 |
11.2 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.9 |
15.4 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.9 |
17.0 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.9 |
7.7 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.8 |
11.8 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.8 |
5.0 |
GO:0045072 |
regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.8 |
2.5 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.8 |
2.5 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 0.8 |
1.6 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.8 |
3.2 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.8 |
1.6 |
GO:1903960 |
negative regulation of anion transmembrane transport(GO:1903960) |
| 0.8 |
19.9 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.8 |
2.4 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.8 |
5.6 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.8 |
2.4 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.8 |
2.3 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.8 |
2.3 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.8 |
3.1 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.8 |
2.3 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.8 |
1.5 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.8 |
4.6 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.8 |
4.6 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.8 |
1.5 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.8 |
6.8 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.8 |
31.1 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.7 |
2.2 |
GO:0010623 |
programmed cell death involved in cell development(GO:0010623) |
| 0.7 |
4.4 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.7 |
6.6 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.7 |
10.9 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.7 |
3.6 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.7 |
5.7 |
GO:0045187 |
regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.7 |
1.4 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.7 |
5.6 |
GO:1990144 |
intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.7 |
2.1 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.7 |
13.4 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.7 |
2.0 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.7 |
1.3 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.7 |
12.4 |
GO:0032210 |
regulation of telomere maintenance via telomerase(GO:0032210) |
| 0.7 |
0.7 |
GO:0045605 |
negative regulation of epidermal cell differentiation(GO:0045605) |
| 0.6 |
6.5 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.6 |
3.2 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.6 |
5.2 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.6 |
3.9 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.6 |
2.6 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.6 |
5.1 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
| 0.6 |
1.9 |
GO:0046686 |
response to cadmium ion(GO:0046686) |
| 0.6 |
1.9 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.6 |
2.5 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.6 |
8.1 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.6 |
16.1 |
GO:0030901 |
midbrain development(GO:0030901) |
| 0.6 |
5.5 |
GO:0009992 |
cellular water homeostasis(GO:0009992) |
| 0.6 |
4.2 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.6 |
3.6 |
GO:0008334 |
histone mRNA metabolic process(GO:0008334) |
| 0.6 |
2.4 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 0.6 |
4.2 |
GO:0018027 |
peptidyl-lysine dimethylation(GO:0018027) |
| 0.6 |
4.7 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.6 |
2.9 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.6 |
1.2 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.6 |
1.7 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.6 |
2.3 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 0.6 |
6.8 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.6 |
3.4 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.6 |
3.4 |
GO:1902861 |
copper ion import into cell(GO:1902861) |
| 0.6 |
2.3 |
GO:0031509 |
pericentric heterochromatin assembly(GO:0031508) telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.6 |
2.3 |
GO:0060536 |
cartilage morphogenesis(GO:0060536) |
| 0.6 |
8.4 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.6 |
10.6 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.6 |
4.4 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.6 |
3.3 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.6 |
1.7 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.5 |
0.5 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.5 |
2.7 |
GO:1900364 |
negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.5 |
4.3 |
GO:0034508 |
centromere complex assembly(GO:0034508) |
| 0.5 |
2.7 |
GO:1900451 |
positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.5 |
1.6 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.5 |
9.1 |
GO:0045672 |
positive regulation of osteoclast differentiation(GO:0045672) |
| 0.5 |
13.8 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.5 |
2.1 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.5 |
1.1 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.5 |
1.6 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.5 |
4.2 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.5 |
1.0 |
GO:0060231 |
mesenchymal to epithelial transition(GO:0060231) |
| 0.5 |
1.0 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) |
| 0.5 |
2.1 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.5 |
2.0 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.5 |
2.5 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.5 |
2.0 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.5 |
3.0 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.5 |
16.4 |
GO:0042632 |
cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.5 |
6.9 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.5 |
7.9 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.5 |
3.4 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.5 |
25.8 |
GO:0071166 |
ribonucleoprotein complex localization(GO:0071166) |
| 0.5 |
4.2 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.5 |
2.8 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.5 |
1.4 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.5 |
3.2 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.5 |
0.9 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.5 |
2.7 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.5 |
1.4 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.5 |
0.9 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.5 |
0.5 |
GO:0071047 |
nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 0.5 |
1.4 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.4 |
1.3 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.4 |
1.8 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.4 |
2.2 |
GO:0016445 |
somatic diversification of immunoglobulins(GO:0016445) |
| 0.4 |
4.0 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.4 |
5.3 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.4 |
0.9 |
GO:0002192 |
IRES-dependent translational initiation(GO:0002192) |
| 0.4 |
6.1 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.4 |
3.4 |
GO:0006972 |
hyperosmotic response(GO:0006972) |
| 0.4 |
1.3 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.4 |
11.0 |
GO:1904031 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.4 |
1.7 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.4 |
1.3 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.4 |
1.3 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.4 |
5.0 |
GO:0051084 |
'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
| 0.4 |
2.9 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.4 |
1.2 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.4 |
5.3 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.4 |
9.7 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.4 |
5.3 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.4 |
1.2 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.4 |
1.6 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.4 |
1.6 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.4 |
4.0 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.4 |
0.4 |
GO:0031441 |
negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.4 |
2.4 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.4 |
3.5 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.4 |
2.7 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.4 |
3.9 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.4 |
2.7 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.4 |
8.5 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.4 |
0.8 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.4 |
9.2 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.4 |
3.8 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.4 |
3.8 |
GO:0034433 |
steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.4 |
4.2 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.4 |
21.1 |
GO:0007292 |
female gamete generation(GO:0007292) |
| 0.4 |
1.5 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.4 |
0.4 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.4 |
1.1 |
GO:0036490 |
regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
| 0.4 |
7.2 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.4 |
1.1 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.3 |
0.7 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.3 |
1.4 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.3 |
6.9 |
GO:0031050 |
dsRNA fragmentation(GO:0031050) production of miRNAs involved in gene silencing by miRNA(GO:0035196) production of small RNA involved in gene silencing by RNA(GO:0070918) |
| 0.3 |
1.7 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.3 |
1.7 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.3 |
3.4 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.3 |
1.0 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.3 |
2.0 |
GO:0018377 |
N-terminal protein lipidation(GO:0006498) N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.3 |
3.0 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.3 |
1.0 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.3 |
2.0 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.3 |
0.7 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.3 |
2.9 |
GO:0097237 |
cellular response to toxic substance(GO:0097237) |
| 0.3 |
3.9 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.3 |
7.0 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.3 |
1.0 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.3 |
3.8 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.3 |
0.3 |
GO:2001012 |
mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.3 |
9.9 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.3 |
9.4 |
GO:0021510 |
spinal cord development(GO:0021510) |
| 0.3 |
9.6 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.3 |
3.5 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.3 |
2.9 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.3 |
2.4 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.3 |
2.0 |
GO:0000478 |
endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.3 |
5.5 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.3 |
4.1 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.3 |
10.2 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.3 |
3.5 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.3 |
8.1 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.3 |
4.6 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.3 |
7.5 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.3 |
0.3 |
GO:1902579 |
multi-organism transport(GO:0044766) multi-organism localization(GO:1902579) |
| 0.3 |
0.3 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.3 |
0.9 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.3 |
5.9 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.3 |
3.0 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.3 |
4.1 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.3 |
1.9 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.3 |
0.5 |
GO:0002922 |
positive regulation of humoral immune response(GO:0002922) |
| 0.3 |
10.4 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.3 |
3.2 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.3 |
1.3 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.3 |
2.7 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.3 |
1.9 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.3 |
12.1 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.3 |
0.5 |
GO:0070200 |
establishment of protein localization to telomere(GO:0070200) |
| 0.3 |
1.3 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.3 |
1.3 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.3 |
8.6 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.3 |
1.8 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.3 |
3.8 |
GO:0006582 |
melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.3 |
0.3 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.2 |
3.7 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.2 |
0.5 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.2 |
4.7 |
GO:0006310 |
DNA recombination(GO:0006310) |
| 0.2 |
0.7 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.2 |
0.7 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.2 |
16.7 |
GO:0045137 |
development of primary sexual characteristics(GO:0045137) |
| 0.2 |
6.4 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.2 |
0.5 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.2 |
2.4 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.2 |
0.7 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 |
8.3 |
GO:0043242 |
negative regulation of actin filament depolymerization(GO:0030835) negative regulation of protein complex disassembly(GO:0043242) negative regulation of protein depolymerization(GO:1901880) |
| 0.2 |
2.1 |
GO:2000010 |
positive regulation of protein localization to cell surface(GO:2000010) |
| 0.2 |
19.4 |
GO:0001841 |
neural tube formation(GO:0001841) |
| 0.2 |
1.4 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.2 |
2.3 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.2 |
5.2 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.2 |
15.8 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.2 |
9.2 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.2 |
1.1 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 |
7.5 |
GO:0035307 |
positive regulation of protein dephosphorylation(GO:0035307) |
| 0.2 |
8.2 |
GO:0045638 |
negative regulation of myeloid cell differentiation(GO:0045638) |
| 0.2 |
1.1 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.2 |
5.7 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.2 |
0.4 |
GO:0022616 |
DNA strand elongation(GO:0022616) |
| 0.2 |
0.7 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 0.2 |
0.4 |
GO:0042518 |
negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
| 0.2 |
0.9 |
GO:0031999 |
negative regulation of fatty acid beta-oxidation(GO:0031999) negative regulation of fatty acid oxidation(GO:0046322) |
| 0.2 |
2.4 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.2 |
1.3 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.2 |
2.0 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.2 |
3.5 |
GO:0070830 |
bicellular tight junction assembly(GO:0070830) |
| 0.2 |
1.6 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.2 |
0.4 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.2 |
0.6 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.2 |
1.6 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 |
2.0 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.2 |
1.7 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.2 |
0.9 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.2 |
3.0 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.2 |
6.5 |
GO:0043039 |
tRNA aminoacylation(GO:0043039) |
| 0.2 |
4.5 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.2 |
27.4 |
GO:0044772 |
mitotic cell cycle phase transition(GO:0044772) |
| 0.2 |
2.4 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.2 |
1.8 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.2 |
2.7 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.2 |
0.4 |
GO:0019081 |
viral translation(GO:0019081) |
| 0.2 |
2.5 |
GO:0010388 |
protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
| 0.2 |
1.8 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.2 |
0.5 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.2 |
3.0 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.2 |
1.2 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.2 |
1.4 |
GO:0001736 |
establishment of planar polarity(GO:0001736) establishment of tissue polarity(GO:0007164) |
| 0.2 |
3.3 |
GO:0071356 |
cellular response to tumor necrosis factor(GO:0071356) |
| 0.2 |
1.3 |
GO:0042136 |
amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) neurotransmitter biosynthetic process(GO:0042136) |
| 0.2 |
1.5 |
GO:0060425 |
lung morphogenesis(GO:0060425) |
| 0.2 |
1.6 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.2 |
1.5 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.2 |
0.3 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 |
0.6 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.2 |
13.3 |
GO:0016072 |
rRNA metabolic process(GO:0016072) |
| 0.2 |
6.8 |
GO:0006400 |
tRNA modification(GO:0006400) |
| 0.2 |
0.8 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.2 |
2.8 |
GO:0043627 |
response to estrogen(GO:0043627) |
| 0.2 |
2.3 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.2 |
0.5 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.2 |
5.1 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.2 |
0.8 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.2 |
0.9 |
GO:2000036 |
regulation of stem cell population maintenance(GO:2000036) |
| 0.1 |
0.3 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 |
0.7 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.1 |
0.6 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.1 |
0.1 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.1 |
0.7 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
0.4 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.1 |
0.4 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.1 |
2.4 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 |
0.8 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.1 |
0.4 |
GO:0009130 |
pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
| 0.1 |
0.4 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
1.0 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.1 |
0.5 |
GO:0051452 |
intracellular pH reduction(GO:0051452) |
| 0.1 |
0.9 |
GO:0061684 |
chaperone-mediated autophagy(GO:0061684) |
| 0.1 |
0.5 |
GO:0043297 |
apical junction assembly(GO:0043297) |
| 0.1 |
0.4 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 |
2.3 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.1 |
0.2 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.1 |
1.0 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.1 |
0.6 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.1 |
1.5 |
GO:0001658 |
branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.1 |
0.9 |
GO:0040001 |
establishment of mitotic spindle localization(GO:0040001) |
| 0.1 |
1.9 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.1 |
0.5 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
1.7 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.1 |
7.0 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.1 |
0.3 |
GO:0034724 |
DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 |
0.4 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.1 |
0.8 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.1 |
0.1 |
GO:0009838 |
abscission(GO:0009838) |
| 0.1 |
1.3 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.1 |
1.9 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 |
1.6 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.1 |
0.2 |
GO:1903596 |
regulation of gap junction assembly(GO:1903596) |
| 0.1 |
2.7 |
GO:0009062 |
fatty acid catabolic process(GO:0009062) |
| 0.1 |
1.0 |
GO:0097006 |
regulation of plasma lipoprotein particle levels(GO:0097006) |
| 0.1 |
0.8 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.1 |
0.6 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
6.1 |
GO:0006260 |
DNA replication(GO:0006260) |
| 0.1 |
0.1 |
GO:1903236 |
regulation of leukocyte tethering or rolling(GO:1903236) |
| 0.1 |
0.5 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.1 |
2.0 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.1 |
4.3 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.1 |
0.6 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
0.3 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.1 |
0.7 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.1 |
0.8 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 0.1 |
3.5 |
GO:0019827 |
stem cell population maintenance(GO:0019827) |
| 0.1 |
0.5 |
GO:0032225 |
regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.1 |
2.8 |
GO:0030218 |
erythrocyte differentiation(GO:0030218) |
| 0.1 |
0.7 |
GO:0008625 |
extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.1 |
3.2 |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.1 |
1.3 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.1 |
0.8 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
0.6 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 |
1.5 |
GO:0071230 |
cellular response to amino acid stimulus(GO:0071230) |
| 0.1 |
3.8 |
GO:0006281 |
DNA repair(GO:0006281) |
| 0.1 |
2.4 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
0.9 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.1 |
0.9 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.4 |
GO:0033146 |
regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
| 0.1 |
1.4 |
GO:0030316 |
osteoclast differentiation(GO:0030316) |
| 0.1 |
0.3 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.1 |
GO:0046888 |
negative regulation of hormone secretion(GO:0046888) |
| 0.1 |
0.7 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.1 |
0.1 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 |
0.1 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.0 |
0.4 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.0 |
0.4 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 |
0.3 |
GO:0007405 |
neuroblast proliferation(GO:0007405) |
| 0.0 |
0.6 |
GO:0033522 |
histone H2A ubiquitination(GO:0033522) |
| 0.0 |
2.3 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.5 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.0 |
0.5 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
9.1 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.0 |
0.6 |
GO:0060395 |
SMAD protein signal transduction(GO:0060395) |
| 0.0 |
0.1 |
GO:0048755 |
branching morphogenesis of a nerve(GO:0048755) |
| 0.0 |
0.9 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.0 |
0.6 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.3 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.1 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.0 |
1.2 |
GO:0042113 |
B cell activation(GO:0042113) |
| 0.0 |
0.1 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.0 |
0.1 |
GO:0008630 |
intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.0 |
0.1 |
GO:0016556 |
mRNA modification(GO:0016556) |
| 0.0 |
0.2 |
GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
| 0.0 |
1.0 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 |
0.1 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.0 |
0.1 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.0 |
0.1 |
GO:1900048 |
positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
| 0.0 |
1.0 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
0.1 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 |
0.7 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.2 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 |
0.1 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.0 |
0.1 |
GO:0044253 |
positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
| 0.0 |
0.3 |
GO:0046856 |
phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
